JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cukingnan, R. A.
Right arrow Articles by Cimochowski, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cukingnan, R. A., Jr
Right arrow Articles by Cimochowski, G. E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 85, 163-173, Copyright © 1983 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Early valve replacement in active infective endocarditis. Results and late survival

RA Cukingnan Jr, JS Carey, JH Wittig and GE Cimochowski

In the past 14 years, 42 patients with active infective endocarditis underwent early valve replacement for severe congestive heart failure, major prosthetic dehiscence, intramyocardial abscesses, sepsis, or major embolization. Blood cultures were positive in 40 patients and the valve tissues were positive in two others. All patients received antimicrobials for from 1 to 4 weeks. Drug addiction was noted in 24%, urinary tract manipulation in 7%, dental work in 5%, contaminated prosthesis in 2%, and unknown cause in 62%. Organisms were predominantly staphylococcal (43%) and streptococcal (41%); the remainder were gram-negative (9%) or fungal (7%). The aortic valve was involved in 72%, mitral in 14%, tricuspid in 7%, and both aortic and mitral in 7%. By the New York Heart Association (NYHA) functional classification, 90% (38/42) were in Class III or IV. Operative mortality was 10% (4/42) and all four patients had preexisting renal failure necessitating dialysis. No predominant organism correlated with early deaths. In aortic valve replacement (30 patients), operative mortality was 7%. Postoperatively, 95% (35/37) were Class I or II with one lost to follow-up. Subsequent reoperation was required in five patients (13%) for recurrent endocarditis, with an operative mortality of 20% (1/5). Late death occurred in 45% (17/38). Overall probability of survival was 0.53 at 5 years. For isolated aortic valve involvement, the 5 year survival was 0.58. Survival for native valve involvement was 0.58 and for prosthetic endocarditis, 0.55. This study shows that after at least 1 week of antibiotics, early operation in patients with active endocarditis has an acceptable operative mortality. Clinical improvement is excellent in 95% and more than half survived 5 years or longer.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
F. J. Baumgartner, B. O. Omari, J. M. Robertson, R. J. Nelson, A. Pandya, A. Pandya, and J. C. Milliken
Annular abscesses in surgical endocarditis: anatomic, clinical, and operative features
Ann. Thorac. Surg., August 1, 2000; 70(2): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Eishi, K. Kawazoe, Y. Kuriyama, Y. Kitoh, Y. Kawashima, and T. Omae
SURGICAL MANAGEMENT OF INFECTIVE ENDOCARDITIS ASSOCIATED WITH CEREBRAL COMPLICATIONSMulti-center retrospective study in Japan
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1745 - 1755.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
F. Nomura, D. J. Penny, S. Menahem, A. Pawade, and T. R. Karl
Surgical intervention for infective endocarditis in infancy and childhood
Ann. Thorac. Surg., July 1, 1995; 60(1): 90 - 95.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Nataf, A. Pavie, F. Jault, V. Bors, C. Cabrol, and I. Gandjbakhch
Intraatrial insertion of a mitral prosthesis in a destroyed or calcified mitral annulus
Ann. Thorac. Surg., July 1, 1994; 58(1): 163 - 167.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
J. L. Balthazar Jacob, A. Menezes Lorga, L. C. da Silveira, A. Parro, R. V. Ardito, and J. C. Nicolau
Valvular Surgery During Infective Endocarditis: Surgical Mortality and Long-Term Follow-up
Vascular and Endovascular Surgery, June 1, 1994; 28(5): 341 - 348.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Watanabe, A. Haverich, R. Speier, C. Dresler, and H. G. Borst
Surgical treatment of active infective endocarditis with paravalvular involvement
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 171 - 177.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. Dreyfus, A. Serraf, V. A. Jebara, A. Deloche, S. Chauvaud, J. P. Couetil, and A. Carpentier
Valve repair in acute endocarditis
Ann. Thorac. Surg., May 1, 1990; 49(5): 706 - 713.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. D. Cowgill, V. P. Addonizio, A. R. Hopeman, and A. H. Harken
A Practical Approach to Prosthetic Valve Endocarditis
Ann. Thorac. Surg., April 1, 1987; 43(4): 450 - 457.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Arbulu and I. Asfaw
Management of Infective Endocarditis: Seventeen Years' Experience
Ann. Thorac. Surg., February 1, 1987; 43(2): 144 - 149.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. W. VanHooser, R. G. Johnson, R. A. Hein, and R. C. Elkins
Successful Management of Aortic Valve Endocarditis with Associated Periannular Abscess and Aneurysm
Ann. Thorac. Surg., August 1, 1986; 42(2): 148 - 151.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1983 by The American Association for Thoracic Surgery.